442 related articles for article (PubMed ID: 1704195)
1. Acetylcholine-induced vasodilatation in rabbit hindlimb in vivo is not inhibited by analogues of L-arginine.
Mügge A; Lopez JA; Piegors DJ; Breese KR; Heistad DD
Am J Physiol; 1991 Jan; 260(1 Pt 2):H242-7. PubMed ID: 1704195
[TBL] [Abstract][Full Text] [Related]
2. The effect of NG-nitro-L-arginine methyl ester upon basal blood flow and endothelium-dependent vasodilatation in the dog hindlimb.
White DG; Drew GM; Gurden JM; Penny DM; Roach AG; Watts IS
Br J Pharmacol; 1993 Mar; 108(3):763-8. PubMed ID: 8467362
[TBL] [Abstract][Full Text] [Related]
3. L-NG-nitro arginine (L-NOARG), a novel, L-arginine-reversible inhibitor of endothelium-dependent vasodilatation in vitro.
Moore PK; al-Swayeh OA; Chong NW; Evans RA; Gibson A
Br J Pharmacol; 1990 Feb; 99(2):408-12. PubMed ID: 2328404
[TBL] [Abstract][Full Text] [Related]
4. N omega-nitro-L-arginine selectively inhibits vasodilator responses to acetylcholine and bradykinin in cats.
Bellan JA; Minkes RK; McNamara DB; Kadowitz PJ
Am J Physiol; 1991 Mar; 260(3 Pt 2):H1025-9. PubMed ID: 2000961
[TBL] [Abstract][Full Text] [Related]
5. The L-arginine-nitric oxide pathway in the canine femoral vascular bed: in vitro and in vivo experiments.
Richard V; Gosgnach M; Drieu la Rochelle C; Giudicelli JF; Berdeaux A
Fundam Clin Pharmacol; 1991; 5(9):777-88. PubMed ID: 1794833
[TBL] [Abstract][Full Text] [Related]
6. Importance of nitric oxide in canine femoral circulation: comparison of two NO inhibitors.
Kirkebøen KA; Naess PA; Christensen G; Kiil F
Cardiovasc Res; 1992 Apr; 26(4):357-61. PubMed ID: 1638567
[TBL] [Abstract][Full Text] [Related]
7. Nitric oxide requirement for vasomotor nerve-induced vasodilatation and modulation of resting blood flow in muscle microcirculation.
Persson MG; Wiklund NP; Gustafsson LE
Acta Physiol Scand; 1991 Jan; 141(1):49-56. PubMed ID: 2053446
[TBL] [Abstract][Full Text] [Related]
8. Selective inhibition of basal but not agonist-stimulated activity of nitric oxide in rat aorta by NG-monomethyl-L-arginine.
Frew JD; Paisley K; Martin W
Br J Pharmacol; 1993 Nov; 110(3):1003-8. PubMed ID: 7507774
[TBL] [Abstract][Full Text] [Related]
9. A specific inhibitor of nitric oxide formation from L-arginine attenuates endothelium-dependent relaxation.
Rees DD; Palmer RM; Hodson HF; Moncada S
Br J Pharmacol; 1989 Feb; 96(2):418-24. PubMed ID: 2924084
[TBL] [Abstract][Full Text] [Related]
10. Role of endothelium-derived nitric oxide in the abnormal endothelium-dependent vascular relaxation of patients with essential hypertension.
Panza JA; Casino PR; Kilcoyne CM; Quyyumi AA
Circulation; 1993 May; 87(5):1468-74. PubMed ID: 8491001
[TBL] [Abstract][Full Text] [Related]
11. Endothelium-derived relaxing factor is likely to modulate the tone of resistance arteries in rabbit hindlimb in vivo.
Förstermann U; Dudel C; Frölich JC
J Pharmacol Exp Ther; 1987 Dec; 243(3):1055-61. PubMed ID: 2447263
[TBL] [Abstract][Full Text] [Related]
12. Role of nitric oxide synthesis in the regulation of coronary vascular tone in the isolated perfused rabbit heart.
Smith RE; Palmer RM; Bucknall CA; Moncada S
Cardiovasc Res; 1992 May; 26(5):508-12. PubMed ID: 1446321
[TBL] [Abstract][Full Text] [Related]
13. Acetylcholine vasodilation of resistance vessels in vivo may not entirely depend on newly synthesized nitric oxide.
Ross G; Chaudhuri G; Ignarro LJ; Chyu KY
Eur J Pharmacol; 1991 Mar; 195(2):291-3. PubMed ID: 1874277
[TBL] [Abstract][Full Text] [Related]
14. The role of nitric oxide in endothelium-dependent vasodilation of hypercholesterolemic patients.
Casino PR; Kilcoyne CM; Quyyumi AA; Hoeg JM; Panza JA
Circulation; 1993 Dec; 88(6):2541-7. PubMed ID: 8252665
[TBL] [Abstract][Full Text] [Related]
15. Vasodilator responses to acetylcholine, bradykinin, and substance P are mediated by a TEA-sensitive mechanism.
Champion HC; Kadowitz PJ
Am J Physiol; 1997 Jul; 273(1 Pt 2):R414-22. PubMed ID: 9249580
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of L-arginine on the inhibition by NG-nitro-L-arginine methyl ester of basal and agonist-stimulated EDRF activity.
Randall MD; Griffith TM
Br J Pharmacol; 1991 Nov; 104(3):743-9. PubMed ID: 1797335
[TBL] [Abstract][Full Text] [Related]
17. Nitric-oxide-related and non-related mechanisms in the acetylcholine-evoked relaxations in cat femoral arteries.
Alonso MJ; Salaices M; Sánchez-Ferrer CF; Ponte A; López-Rico M; Marín J
J Vasc Res; 1993; 30(6):339-47. PubMed ID: 7694666
[TBL] [Abstract][Full Text] [Related]
18. Nitric oxide does not mediate flow induced endothelium dependent arterial dilatation in the cat.
Melkumyants AM; Balashov SA; Klimachev AN; Kartamyshev SP; Khayutin VM
Cardiovasc Res; 1992 Mar; 26(3):256-60. PubMed ID: 1423421
[TBL] [Abstract][Full Text] [Related]
19. Endothelial dysfunction of hindquarter resistance vessels in experimental heart failure.
Drexler H; Lu W
Am J Physiol; 1992 Jun; 262(6 Pt 2):H1640-5. PubMed ID: 1621825
[TBL] [Abstract][Full Text] [Related]
20. Contribution of nitric oxide to metabolic coronary vasodilation in the human heart.
Quyyumi AA; Dakak N; Andrews NP; Gilligan DM; Panza JA; Cannon RO
Circulation; 1995 Aug; 92(3):320-6. PubMed ID: 7634444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
